Simulations Plus ROA 2010-2024 | SLP
Current and historical return on assets (ROA) values for Simulations Plus (SLP) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Simulations Plus ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2024-02-29 |
$0.01B |
$0.19B |
5.91% |
| 2023-11-30 |
$0.01B |
$0.19B |
6.08% |
| 2023-08-31 |
$0.01B |
$0.19B |
5.49% |
| 2023-05-31 |
$0.01B |
$0.18B |
5.48% |
| 2023-02-28 |
$0.01B |
$0.17B |
5.43% |
| 2022-11-30 |
$0.01B |
$0.19B |
5.34% |
| 2022-08-31 |
$0.01B |
$0.19B |
6.49% |
| 2022-05-31 |
$0.01B |
$0.19B |
6.01% |
| 2022-02-28 |
$0.01B |
$0.19B |
6.07% |
| 2021-11-30 |
$0.01B |
$0.18B |
5.59% |
| 2021-08-31 |
$0.01B |
$0.18B |
5.11% |
| 2021-05-31 |
$0.01B |
$0.18B |
6.35% |
| 2021-02-28 |
$0.01B |
$0.18B |
6.94% |
| 2020-11-30 |
$0.01B |
$0.17B |
8.02% |
| 2020-08-31 |
$0.01B |
$0.17B |
11.01% |
| 2020-05-31 |
$0.01B |
$0.06B |
17.65% |
| 2020-02-29 |
$0.01B |
$0.05B |
19.15% |
| 2019-11-30 |
$0.01B |
$0.05B |
19.78% |
| 2019-08-31 |
$0.01B |
$0.05B |
20.45% |
| 2019-05-31 |
$0.01B |
$0.05B |
18.39% |
| 2019-02-28 |
$0.01B |
$0.04B |
16.37% |
| 2018-11-30 |
$0.01B |
$0.04B |
18.93% |
| 2018-08-31 |
$0.01B |
$0.04B |
19.16% |
| 2018-05-31 |
$0.01B |
$0.04B |
19.63% |
| 2018-02-28 |
$0.01B |
$0.04B |
21.33% |
| 2017-11-30 |
$0.01B |
$0.04B |
17.39% |
| 2017-08-31 |
$0.01B |
$0.04B |
15.75% |
| 2017-05-31 |
$0.01B |
$0.03B |
17.24% |
| 2017-02-28 |
$0.01B |
$0.03B |
17.39% |
| 2016-11-30 |
$0.01B |
$0.03B |
17.54% |
| 2016-08-31 |
$0.01B |
$0.03B |
17.70% |
| 2016-05-31 |
$0.00B |
$0.03B |
14.29% |
| 2016-02-29 |
$0.00B |
$0.03B |
14.41% |
| 2015-11-30 |
$0.00B |
$0.03B |
14.55% |
| 2015-08-31 |
$0.00B |
$0.03B |
14.68% |
| 2015-05-31 |
$0.00B |
$0.03B |
15.53% |
| 2015-02-28 |
$0.00B |
$0.03B |
12.37% |
| 2014-11-30 |
$0.00B |
$0.03B |
13.79% |
| 2014-08-31 |
$0.00B |
$0.02B |
15.79% |
| 2014-05-31 |
$0.00B |
$0.02B |
16.90% |
| 2014-02-28 |
$0.00B |
$0.02B |
18.46% |
| 2013-11-30 |
$0.00B |
$0.02B |
18.75% |
| 2013-08-31 |
$0.00B |
$0.02B |
18.46% |
| 2013-05-31 |
$0.00B |
$0.02B |
18.18% |
| 2013-02-28 |
$0.00B |
$0.02B |
17.65% |
| 2012-11-30 |
$0.00B |
$0.02B |
16.90% |
| 2012-08-31 |
$0.00B |
$0.02B |
16.90% |
| 2012-05-31 |
$0.00B |
$0.02B |
17.14% |
| 2012-02-29 |
$0.00B |
$0.02B |
17.65% |
| 2011-11-30 |
$0.00B |
$0.02B |
18.75% |
| 2011-08-31 |
$0.00B |
$0.02B |
19.67% |
| 2011-05-31 |
$0.00B |
$0.02B |
20.00% |
| 2011-02-28 |
$0.00B |
$0.02B |
20.34% |
| 2010-11-30 |
$0.00B |
$0.01B |
20.69% |
| 2010-08-31 |
$0.00B |
$0.02B |
14.04% |
| 2010-05-31 |
$0.00B |
$0.02B |
14.81% |
| 2010-02-28 |
$0.00B |
$0.01B |
15.38% |
| 2009-11-30 |
$0.00B |
$0.01B |
7.84% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Computer Software |
$0.912B |
$0.060B |
|
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
|
